Simmons Bank Novartis Ag Transaction History

Simmons Bank

$1.39 Billion
Q2 2025

A detailed history of Simmons Bank transactions in Novartis Ag stock. As of the latest transaction made, Simmons Bank holds 8,729 shares of NVS stock, worth $1.14 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

8,729

Previous 9,174 4.85%

Holding current value

$1.14 Million

Previous $1.02 Million 3.33%

% of portfolio

0.08%

Previous 0.08%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	SELL	$101.96 - $121.01 $45,372 - $53,849	-445 Reduced 4.85%	8,729 $1.06 Million
Q1 2025 Apr 29, 2025	SELL	$97.14 - $115.57 $3,691 - $4,391	-38 Reduced 0.41%	9,174 $1.02 Million
Q4 2024 Feb 04, 2025	SELL	$96.78 - $117.18 $7,258 - $8,788	-75 Reduced 0.81%	9,212 $896,000
Q3 2024 Nov 05, 2024	SELL	$106.13 - $120.89 $24,622 - $28,046	-232 Reduced 2.44%	9,287 $1.07 Million
Q2 2024 Jul 26, 2024	SELL	$92.57 - $107.37 $18,976 - $22,010	-205 Reduced 2.11%	9,519 $1.01 Million
Q1 2024 May 14, 2024	BUY	$95.27 - $108.47 $1,143 - $1,301	12 Added 0.12%	9,724 $940,000
Q3 2023 Oct 26, 2023	SELL	$94.73 - $105.13 $10,988 - $12,195	-116 Reduced 1.18%	9,712 $989,000
Q2 2023 Aug 03, 2023	SELL	$92.52 - $104.91 $11,102 - $12,589	-120 Reduced 1.21%	9,828 $991,000
Q1 2023 Apr 28, 2023	SELL	$80.03 - $92.81 $31,051 - $36,010	-388 Reduced 3.75%	9,948 $915,000
Q4 2022 Feb 08, 2023	SELL	$75.55 - $92.52 $755 - $925	-10 Reduced 0.1%	10,336 $937,000
Q3 2022 Oct 27, 2022	SELL	$74.61 - $87.26 $43,273 - $50,610	-580 Reduced 5.31%	10,346 $786,000
Q2 2022 Jul 29, 2022	SELL	$80.52 - $93.75 $63,208 - $73,593	-785 Reduced 6.7%	10,926 $923,000
Q1 2022 Apr 21, 2022	SELL	$80.11 - $90.62 $16,983 - $19,211	-212 Reduced 1.78%	11,711 $1.03 Million
Q4 2021 Jan 28, 2022	SELL	$79.7 - $88.13 $7,252 - $8,019	-91 Reduced 0.76%	11,923 $1.04 Million
Q3 2021 Oct 26, 2021	SELL	$81.78 - $95.14 $27,232 - $31,681	-333 Reduced 2.7%	12,014 $982,000
Q2 2021 Aug 05, 2021	SELL	$85.24 - $94.15 $60,435 - $66,752	-709 Reduced 5.43%	12,347 $1.13 Million
Q1 2021 May 06, 2021	SELL	$83.5 - $98.47 $38,326 - $45,197	-459 Reduced 3.4%	13,056 $1.12 Million
Q4 2020 Feb 08, 2021	SELL	$78.07 - $94.43 $396,751 - $479,893	-5,082 Reduced 27.33%	13,515 $1.28 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $77,129 - $85,449	-939 Reduced 4.81%	18,597 $1.62 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $198,602 - $223,559	2,454 Added 14.37%	19,536 $1.71 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $311,018 - $435,743	4,401 Added 34.71%	17,082 $1.41 Million
Q4 2019 Jan 31, 2020	SELL	$84.35 - $95.37 $82,578 - $93,367	-979 Reduced 7.17%	12,681 $1.2 Million
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $9,067 - $9,991	-106 Reduced 0.77%	13,660 $1.19 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $3,770 - $4,640	-50 Reduced 0.36%	13,766 $1.26 Million
Q1 2019 May 13, 2019	SELL	$75.32 - $86.15 $3,163 - $3,618	-42 Reduced 0.3%	13,816 $1.33 Million
Q4 2018 Jan 24, 2019	SELL	$73.66 - $82.02 $22,908 - $25,508	-311 Reduced 2.19%	13,858 $1.19 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $25,437 - $29,423	380 Added 2.76%	14,169 $1.22 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $21,117 - $25,245	-300 Reduced 2.13%	13,789 $1.12 Million
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $31,825 - $34,161	-440 Reduced 3.03%	14,089 $1.18 Million
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $16,681 - $17,385	-225 Reduced 1.53%	14,529 $1.25 Million
Q2 2017 Aug 15, 2017	BUY	N/A	14,754	14,754 $1.23 Million

Others Institutions Holding NVS

# of Institutions

1,560

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $281B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.

Account